Cargando…
SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors
Understanding the hallmarks of the immune response to SARS-CoV-2 is critical for fighting the COVID-19 pandemic. We assessed antibody and T cell reactivity in convalescent COVID-19 patients and healthy donors sampled both prior to and during the pandemic. Healthy donors examined during the pandemic...
Autores principales: | Shomuradova, Alina S., Vagida, Murad S., Sheetikov, Savely A., Zornikova, Ksenia V., Kiryukhin, Dmitry, Titov, Aleksei, Peshkova, Iuliia O., Khmelevskaya, Alexandra, Dianov, Dmitry V., Malasheva, Maria, Shmelev, Anton, Serdyuk, Yana, Bagaev, Dmitry V., Pivnyuk, Anastasia, Shcherbinin, Dmitrii S., Maleeva, Alexandra V., Shakirova, Naina T., Pilunov, Artem, Malko, Dmitry B., Khamaganova, Ekaterina G., Biderman, Bella, Ivanov, Alexander, Shugay, Mikhail, Efimov, Grigory A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664363/ https://www.ncbi.nlm.nih.gov/pubmed/33326767 http://dx.doi.org/10.1016/j.immuni.2020.11.004 |
Ejemplares similares
-
Transgenic HA-1-Specific CD8(+) T-Lymphocytes Selectively Target Leukemic Cells
por: Pilunov, Artem, et al.
Publicado: (2023) -
Immunogenic epitope panel for accurate detection of non-cross-reactive T cell response to SARS-CoV-2
por: Titov, Aleksei, et al.
Publicado: (2022) -
Clonal diversity predicts persistence of SARS-CoV-2 epitope-specific T-cell response
por: Zornikova, Ksenia V., et al.
Publicado: (2022) -
Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: Data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia
por: Lioznov, Dmitry, et al.
Publicado: (2023) -
Rapid Multiplex Genotyping of 20 HLA-A(*)02:01 Restricted Minor Histocompatibility Antigens
por: Romaniuk, Dmitrii S., et al.
Publicado: (2019)